Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MYCN Antikörper

MYCN Reaktivität: Human, Maus, Ratte WB, IF Wirt: Maus Monoclonal NMYC-1 unconjugated
Produktnummer ABIN6940152
  • Target Alle MYCN Antikörper anzeigen
    MYCN (N-Myc Proto-Oncogene Protein (MYCN))
    Reaktivität
    • 30
    • 16
    • 13
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Human, Maus, Ratte
    Wirt
    • 29
    • 6
    Maus
    Klonalität
    • 31
    • 4
    Monoklonal
    Konjugat
    • 25
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser MYCN Antikörper ist unkonjugiert
    Applikation
    • 23
    • 14
    • 6
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF)
    Aufreinigung
    Purified by Protein A/G
    Immunogen
    Recombinant full-length human n-Myc protein.
    Klon
    NMYC-1
    Isotyp
    IgG2a kappa
    Top Product
    Discover our top product MYCN Primärantikörper
  • Applikationshinweise

    Positive Control: 293T whole cell lysates or recombinant Human n-Myc protein.

    Known Application: Immunofluorescence (0.5-1 μg/mL), Western Blot (0.5-1.0 μg/mL)Optimal dilution for a specific application should be determined.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    200 μg/mL
    Buffer
    10 mM PBS with 0.05 % BSA & 0.05 % azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-80 °C
    Informationen zur Lagerung
    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
    Haltbarkeit
    24 months
  • Target
    MYCN (N-Myc Proto-Oncogene Protein (MYCN))
    Andere Bezeichnung
    MYCN (MYCN Produkte)
    Synonyme
    MODED antikoerper, MYCNOT antikoerper, N-myc antikoerper, NMYC antikoerper, ODED antikoerper, bHLHe37 antikoerper, Nmyc antikoerper, Nmyc-1 antikoerper, Nmyc1 antikoerper, c-nmyc antikoerper, Nmuc1 antikoerper, fb57a02 antikoerper, nmyc1 antikoerper, wu:fb57a02 antikoerper, zgc:85706 antikoerper, XN-myc antikoerper, XNmyc antikoerper, mycn antikoerper, mycn-a antikoerper, mycn-b antikoerper, mycna antikoerper, xN-myc1 antikoerper, MYCN proto-oncogene, bHLH transcription factor antikoerper, v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog antikoerper, v-myc avian myelocytomatosis viral related oncogene, neuroblastoma derived antikoerper, olfactory receptor 8S1 antikoerper, MYCN proto-oncogene, bHLH transcription factor S homeolog antikoerper, MYCN antikoerper, Mycn antikoerper, LOC515887 antikoerper, mycn antikoerper, mycn.S antikoerper
    Hintergrund
    The v-Myc oncogene, initially identified in the MC29 avian retrovirus, causes myelocytomas, carcinomas, sarcomas and lymphomas, and belongs to a family of oncogenes conserved throughout evolution. In humans, the family consists of five genes: c-Myc, N-Myc, R-Myc, L-Myc and B-Myc. Amplification of the N-Myc gene has been found in human neuroblastomas and cell lines. Its amplification correlates well with the stage of neuroblastoma disease. Immunological studies have shown that the human N-Myc gene encodes a nuclear phosphoprotein that exhibits relatively short (30 min) half life in vivo. The prototype member of the family, c-Myc p67, binds DNA in a sequence-specific manner subsequent to dimerization with a second basic region helix-loop-helix leucine zipper motif protein, designated Max.
    Molekulargewicht
    67kDa
    Gen-ID
    4613
    UniProt
    P04198
Sie sind hier:
Kundenservice